Send SMS
+918045800513
Ceftriaxone 125 mg & Sulbactam 62.5 mg
Ceftriaxone 125 mg & Sulbactam 62.5 mg Ceftriaxone 125 mg & Sulbactam 62.5 mg
Ceftriaxone 125 mg & Sulbactam 62.5 mg Ceftriaxone 125 mg & Sulbactam 62.5 mg Ceftriaxone 125 mg & Sulbactam 62.5 mg

Ceftriaxone 125 mg & Sulbactam 62.5 mg

10.00 - 80.00 INR

Product Details:

  • Drug Type Injection
  • Ingredients Ceftriaxone 125 mg + Sulbactam 62.5 mg
  • Physical Form Powder
  • Function Antibiotic Medicine
  • Recommended For Moderate to chronic infectioons
  • Dosage Pediatric:50 to 180 mg/kg in 4-6 divided doses (Dose calc. is based on Ceftriaxone)
  • Dosage Guidelines Adult: Uncomplicated Infections-1 gm,every 12 hr. Moderate to Severe Infections: 1-2 grams every 8 hr. Life-threatening Infections upto 2-12 gm after every 4 hr Cesarean Patients: First dose of 1 gm is administered intravenously a s soon as the umbilical cord is clamped.Second and Third doses should be given as 1 gram IV at 6 and 12 hr after the final dose. Pediatric:50 to 180 mg/kg in 4-6 divided doses (Dose calc. is based on Ceftriaxone)
  • Supply Ability : 100000 Box Per Month
  • Click to view more
X

Price And Quantity

  • 500 Box
  • 10.00 - 80.00 INR

Product Specifications

  • Powder
  • Ceftriaxone 125 mg + Sulbactam 62.5 mg
  • Pediatric:50 to 180 mg/kg in 4-6 divided doses (Dose calc. is based on Ceftriaxone)
  • Antibiotic Medicine
  • Moderate to chronic infectioons
  • Adult: Uncomplicated Infections-1 gm,every 12 hr. Moderate to Severe Infections: 1-2 grams every 8 hr. Life-threatening Infections upto 2-12 gm after every 4 hr Cesarean Patients: First dose of 1 gm is administered intravenously a s soon as the umbilical cord is clamped.Second and Third doses should be given as 1 gram IV at 6 and 12 hr after the final dose. Pediatric:50 to 180 mg/kg in 4-6 divided doses (Dose calc. is based on Ceftriaxone)
  • Injection

Trade Information

  • 100000 Box Per Month
  • 4 Week
  • 1 Vial Packaging
  • All India
  • WHO-GMP

Product Description

Ceftriaxone:
  • Highly effective against multidrug resistant gram negative bacteria responsible for complicated and uncomplicated UTIs & LRTIs.
  • Shows better improvement in clinical features & hospital stay associated with adult pyogenic meningitis than Benzylpenicillin.
Combination:
  • Combination with sulbactam, a beta-lactamase inhibitor results in better bactericidal activity & reduces probability of resistance development.
  • Show 93.6% cure rates in patients with lower respiratory tract infections.

SOLITAIRE PHARMACIA PVT. LTD.

* Tips on getting accurate quotes. Please include product name, order quantity, usage, special requests if any in your inquiry.

Other Products in 'Pharmaceutical Injectables' category



Back to top